A novel method for evaluating enhancement using gadolinium-ethoxybenzyl-diethylenetriamine penta-acetic acid in the hepatobiliary phase of magnetic resonance imaging

Yasuo Takatsu, Satoshi Kobayashi, Tosiaki Miyati, Toshiki Shiozaki

Research output: Contribution to journalArticlepeer-review

9 Citations (Scopus)

Abstract

To investigate whether quantitative liver-portal vein contrast ratio (Q-LPC) can be used as a substitute for quantitative liver-spleen contrast ratio (Q-LSC) in the hepatobiliary phase (HBP) contrasting degree. Q-LSC and Q-LPC were calculated in HBP images that were obtained approximately 20 min after gadolinium-ethoxybenzyl-diethylenetriamine penta-acetic acid injection, and relationship between them was evaluated. A very strong correlation was observed between Q-LSC and Q-LPC with respect to Child–Pugh class. Furthermore, Q-LPC values were not significantly different between patients with splenectomy or Gamna–Gandy bodies and those without. Therefore, Q-LPC can be useful instead of Q-LSC in patients with splenectomy or Gamna–Gandy bodies.

Original languageEnglish
Pages (from-to)1112-1117
Number of pages6
JournalClinical Imaging
Volume40
Issue number6
DOIs
Publication statusPublished - 01-11-2016
Externally publishedYes

All Science Journal Classification (ASJC) codes

  • Radiology Nuclear Medicine and imaging

Fingerprint

Dive into the research topics of 'A novel method for evaluating enhancement using gadolinium-ethoxybenzyl-diethylenetriamine penta-acetic acid in the hepatobiliary phase of magnetic resonance imaging'. Together they form a unique fingerprint.

Cite this